Abstract

Evaluation of renal dysfunction includes estimation of glomerular filtration rate (eGFR) as the initial step and subsequent laboratory testing. We hypothesized that combined analysis of serum creatinine, myo-inositol, dimethyl sulfone, and valine would allow both assessment of renal dysfunction and precise GFR estimation. Bio-banked sera were analyzed using nuclear magnetic resonance spectroscopy (NMR). The metabolites were combined into a metabolite constellation (GFRNMR) using n = 95 training samples and tested in n = 189 independent samples. Tracer-measured GFR (mGFR) served as a reference. GFRNMR was compared to eGFR based on serum creatinine (eGFRCrea and eGFREKFC), cystatin C (eGFRCys-C), and their combination (eGFRCrea-Cys-C) when available. The renal biomarkers provided insights into individual renal and metabolic dysfunction profiles in selected mGFR-matched patients with otherwise homogenous clinical etiology. GFRNMR correlated better with mGFR (Pearson correlation coefficient r = 0.84 vs. 0.79 and 0.80). Overall percentages of eGFR values within 30% of mGFR for GFRNMR matched or exceeded those for eGFRCrea and eGFREKFC (81% vs. 64% and 74%), eGFRCys-C (81% vs. 72%), and eGFRCrea-Cys-C (81% vs. 81%). GFRNMR was independent of patients’ age and sex. The metabolite-based NMR approach combined metabolic characterization of renal dysfunction with precise GFR estimation in pediatric and adult patients in a single analytical step.

Highlights

  • In use for decades, the methods available for estimating glomerular filtration rate with endogenous markers still present important drawbacks [1,2] and were described to be a weak link in renal diagnostics [3]

  • It was concluded that a single filtration marker is unlikely to successfully overcome the limitations of endogenous metabolites, because of variables affecting the pathophysiology of chronic kidney disease (CKD) other than

  • The persistence of these limitations prompted Porrini et al to suggests that the problem perse might be associated with the biochemical natureof creatinine and cystatin C as markers of renal function, rather than with the mathematical methods used for GFR estimation [8]

Read more

Summary

Introduction

In use for decades, the methods available for estimating glomerular filtration rate (eGFR) with endogenous markers still present important drawbacks [1,2] and were described to be a weak link in renal diagnostics [3]. We aimed at a more complex approach that interprets multiple biomarkers reflecting both the glomerular filtration rate and CKD-associated renal dysfunction Such an approach requires the quantification of several renal biomarkers with high precision and accuracy. We hypothesized that NMR-based analysis of myo-inositol as a marker of uremia, dimethyl sulfone as a marker of oxidative stress, and valine as an indicator of acid-base metabolism in combination with creatinine would provide a ‘metabolite constellation’ that describes the complex renal and metabolic dysfunction in CKD. We tested whether this framework would allow a precise estimation of glomerular filtration

Cohorts and Samples
Benchmarking
Biomarker Quantification
Precision
Linearity
GFR Modeling
Model Selection
GFR Estimation
Subgroup Analysis of GFRNMR According to Sex and Age
Molecular Phenotyping by Matched Sample Sets

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.